Tue, Sep 2, 2014, 12:34 AM EDT - U.S. Markets open in 8 hrs 56 mins

Recent

% | $
Quotes you view appear here for quick access.

Alkermes plc Message Board

  • biotechlion@rocketmail.com biotechlion Oct 13, 2010 10:16 AM Flag

    The drug is worth 1 billion- AWESOME

    Jefferies & Co. analyst David Windley said the market for opioid addiction treatments is worth about $1 billion, and he believes Vivitrol would be a success if it is used in 10 percent to 20 percent of cases. That would be a major boost to its annual sales, which he said are currently about $25 million. Windley expects Alkermes to report $40 million in Vivitrol revenue in 2011.

    I don't understand why he said only 41 million for 2011. Only if 10,000(out of 1.6 million patients) patients are enrolled total sales will be aroung 100 million.

 
ALKS
44.73+0.25(+0.56%)Aug 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Exelixis, Inc.
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT
Criteo SA
NasdaqGSFri, Aug 29, 2014 4:00 PM EDT